Inaktiver Wert

Andere Sprachen Midatech Pharma PLC Nasdaq

Aktien

US59564R1041

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading	16.05.
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Wednesday Trading	15.05.
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading	14.05.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading; End Week Up Nearly 3%	10.05.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Wednesday Trading	08.05.
Bank Stocks Lead European Equities Traded in the US as American Depositary Receipts Higher Tuesday	07.05.
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	06.05.
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Set to Close Week Lower	03.05.
European Equities Traded in the US as American Depositary Receipts Rise Modestly Higher in Thursday Trading	02.05.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Lower in Wednesday Trading	01.05.
Biodexa’s Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual Meeting	30.04.
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading	29.04.
Sector Update: Health Care Stocks Edge Higher Late Afternoon	26.04.
Sector Update: Health Care Stocks Higher in Afternoon Trading	26.04.
European Equities Close Higher in Friday Trading; Anglo American Rejects BHP Takeover Bid	26.04.
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading, End Week Up 3.4%	26.04.
Biodexa Pharmaceuticals Gets Exclusive License for Phase 3 Ready Drug to Treat Familial Adenomatous Polyposis -- Shares Jump	26.04.
Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready Asset for the Treatment of Familial Adenomatous Polyposis (FAP)	26.04.
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	25.04.
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading	24.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Midatech Pharma PLC Nasdaq

Aktien

US59564R1041

Andere Sprachen

Filter